• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    NRX Pharmaceuticals, Inc. - Common Stock (NQ:NRXP)

    3.845 +0.625 (+19.41%)
    Streaming Delayed Price Updated: 11:06 AM EDT, May 26, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,276,170
    Open 3.290
    Bid (Size) 3.840 (600)
    Ask (Size) 3.850 (1,300)
    Prev. Close 3.220
    Today's Range 3.260 - 3.980
    52wk Range 1.620 - 3.840
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    My Top 3 Biotech Stocks for May 2026 ↗
    As FDA activity accelerates and big pharma searches for its next generation of blockbuster drugs, select biotech companies are beginning to stand out from the crowd. 
    Via The Motley Fool
    Topics Artificial Intelligence Intellectual Property
    News headline image
    NRx Pharmaceuticals Q1 Earnings Call Highlights ↗
    NRx Pharmaceuticals (NASDAQ:NRXP) said it advanced several regulatory, manufacturing and clinical initiatives during the first quarter of 2026, including progress toward potential approval of its... 
    Via MarketBeat
    Topics Earnings

    Performance

    YTD
    +46.8%
    +46.8%
    1 Month
    +26.9%
    +26.9%
    3 Month
    +118.5%
    +118.5%
    6 Month
    +71.7%
    +71.7%
    1 Year
    +49.0%
    +49.0%

    More News

    Read More
    News headline image
    NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2026 Financial Results and Provides Corporate Update
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    New to The Street's Show #753 Airs Nationwide on Bloomberg Television Across the U.S., MENA and Latin America Featuring FreeCast (NASDAQ:CAST), Stardust Power (NASDAQ:SDST), Lost Soldier Oil and Gas, Virtuix Holdings (NASDAQ:VTIX), and Medicus Pharma
    Via ACCESS Newswire
    News headline image
    NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report First Quarter 2026 Financial Results and Provide Corporate Update
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    InvestorNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Clearance for Depression and Suicidality Trial
    Via Investor Brand Network
    News headline image
    NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Clearance to Proceed with Clinical Trial of NRX-101 in Combination with Robotic-enabled Transcranial Magnetic Stimulation in Patients with Depression and Suicidality
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Initiates First Commercial Manufacturing Order For Preservative-Free Ketamine
    Via Investor Brand Network
    News headline image
    NRx Pharmaceuticals (Nasdaq:NRXP) Announces Initiation of Commercial Manufacturing for Preservative Free Ketamine
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    GLOBAL MARKETS SPOTLIGHT: New to The Street Show #748 Delivers High-Impact CEO Interviews and Spotlight TV Commercials Across Bloomberg to 250M+ Households Worldwide
    Via ACCESS Newswire
    News headline image
    New to The Street Broadcasts Show #746 Tonight on Bloomberg Television 6:30PM EST Featuring NRx Pharma (NASDAQ:NRXP), Performance Golf, Lost Soldier Oil & Gas, Dr. Lee Gause, and CISO Global
    Via ACCESS Newswire
    News headline image
    Positive FDA Response on Preservative-Free Ketamine After President Trump Orders Accelerated Approval for Psychedelic Medication Developers Including NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
    Via Get News
    Topics Government
    BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives Positive FDA Review Letter Supporting Ketamine ANDA Progress
    Via Investor Brand Network
    News headline image
    NRx Pharmaceuticals Reports Positive FDA Office of Generic Drugs Feedback on Preservative-Free Ketamine Program
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Presidential Executive Order to Accelerate Approval of Psychedelic Medications; Those Being Developed by NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
    Via Get News
    Topics Government
    BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Supports Executive Order To Accelerate Psychedelic Drug Development
    Via Investor Brand Network
    News headline image
    NRx Pharmaceuticals (Nasdaq:NRXP) Welcomes Presidential Initiative to Accelerate Approval of Psychedelic Medications to Treat Depression, PTSD, and Suicidality
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Military and First Responder Opportunity for Robotic-Enabled Transcranial Magnetic Stimulation via Neuroplastic Therapy from NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
    Via Get News
    DefenseNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Forms NRx Defense Systems Subsidiary to Advance Neuroplastic Therapies for Military and Government Applications
    Via Investor Brand Network
    BioMedNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Forms NRx Defense Systems Subsidiary to Advance Neuroplastic Therapies for Military and Government Applications
    Via Investor Brand Network
    News headline image
    NRx Pharmaceuticals Advances Robotic-Enabled Transcranial Magnetic Stimulation Combined with Neuroplastic Therapy for Military and First Responder Applications
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Appoints First Chief Commercial Officer Ahead of Ketamine Launch
    Via Investor Brand Network
    News headline image
    NRx Pharmaceuticals (Nasdaq:NRXP) Announces Appointment of Glenn Tyson as the Company’s first Chief Commercial Officer
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Labeling Feedback for Preservative-Free Ketamine Application
    Via Investor Brand Network
    News headline image
    NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx’s Preservative-Free Ketamine Application
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is NRX Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, NRX Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does NRX Pharmaceuticals, Inc. - Common Stock trade on?
    NRX Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for NRX Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for NRX Pharmaceuticals, Inc. - Common Stock is NRXP on the Nasdaq Stock Market
    What is the current price of NRX Pharmaceuticals, Inc. - Common Stock?
    The current price of NRX Pharmaceuticals, Inc. - Common Stock is 3.845
    When was NRX Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of NRX Pharmaceuticals, Inc. - Common Stock was at 05/26/26 11:06 AM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.